Current Status of Breast Organoid Models

Breast cancer (BC) is the most frequently diagnosed malignancy among women globally. Although mouse models have been critical in advancing the knowledge of BC tumorigenesis and progression, human breast models comprising the breast tissue microenvironment are needed to help elucidate the underlying...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Srivarshini Cherukupalli Mohan, Tian-Yu Lee, Armando E. Giuliano, Xiaojiang Cui
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/5f47b17769754222a1e82e54d208dedb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5f47b17769754222a1e82e54d208dedb
record_format dspace
spelling oai:doaj.org-article:5f47b17769754222a1e82e54d208dedb2021-11-05T06:32:48ZCurrent Status of Breast Organoid Models2296-418510.3389/fbioe.2021.745943https://doaj.org/article/5f47b17769754222a1e82e54d208dedb2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.745943/fullhttps://doaj.org/toc/2296-4185Breast cancer (BC) is the most frequently diagnosed malignancy among women globally. Although mouse models have been critical in advancing the knowledge of BC tumorigenesis and progression, human breast models comprising the breast tissue microenvironment are needed to help elucidate the underlying mechanisms of BC risk factors. As such, it is essential to identify an ex vivo human breast tissue mimetic model that can accurately pinpoint the effects of these factors in BC development. While two-dimensional models have been invaluable, they are not suitable for studying patient-specific tumor biology and drug response. Recent developments in three-dimensional (3D) models have led to the prominence of organized structures grown in a 3D environment called “organoids.” Breast organoids can accurately recapitulate the in vivo breast microenvironment and have been used to examine factors that affect signaling transduction, gene expression, and tissue remodeling. In this review, the applications, components, and protocols for development of breast organoids are discussed. We summarize studies that describe the utility of breast organoids, including in the study of normal mammary gland development and tumorigenesis. Finally, we provide an overview of protocols for development of breast organoids, and the advantages and disadvantages of different techniques in studies are described. The included studies have shown that breast organoids will continue to serve as a crucial platform for understanding of progression of BC tumors and the testing of novel therapeutics.Srivarshini Cherukupalli MohanTian-Yu LeeArmando E. GiulianoXiaojiang CuiFrontiers Media S.A.articlebreast organoids3D culturecancermatrixmammary organoidsBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic breast organoids
3D culture
cancer
matrix
mammary organoids
Biotechnology
TP248.13-248.65
spellingShingle breast organoids
3D culture
cancer
matrix
mammary organoids
Biotechnology
TP248.13-248.65
Srivarshini Cherukupalli Mohan
Tian-Yu Lee
Armando E. Giuliano
Xiaojiang Cui
Current Status of Breast Organoid Models
description Breast cancer (BC) is the most frequently diagnosed malignancy among women globally. Although mouse models have been critical in advancing the knowledge of BC tumorigenesis and progression, human breast models comprising the breast tissue microenvironment are needed to help elucidate the underlying mechanisms of BC risk factors. As such, it is essential to identify an ex vivo human breast tissue mimetic model that can accurately pinpoint the effects of these factors in BC development. While two-dimensional models have been invaluable, they are not suitable for studying patient-specific tumor biology and drug response. Recent developments in three-dimensional (3D) models have led to the prominence of organized structures grown in a 3D environment called “organoids.” Breast organoids can accurately recapitulate the in vivo breast microenvironment and have been used to examine factors that affect signaling transduction, gene expression, and tissue remodeling. In this review, the applications, components, and protocols for development of breast organoids are discussed. We summarize studies that describe the utility of breast organoids, including in the study of normal mammary gland development and tumorigenesis. Finally, we provide an overview of protocols for development of breast organoids, and the advantages and disadvantages of different techniques in studies are described. The included studies have shown that breast organoids will continue to serve as a crucial platform for understanding of progression of BC tumors and the testing of novel therapeutics.
format article
author Srivarshini Cherukupalli Mohan
Tian-Yu Lee
Armando E. Giuliano
Xiaojiang Cui
author_facet Srivarshini Cherukupalli Mohan
Tian-Yu Lee
Armando E. Giuliano
Xiaojiang Cui
author_sort Srivarshini Cherukupalli Mohan
title Current Status of Breast Organoid Models
title_short Current Status of Breast Organoid Models
title_full Current Status of Breast Organoid Models
title_fullStr Current Status of Breast Organoid Models
title_full_unstemmed Current Status of Breast Organoid Models
title_sort current status of breast organoid models
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5f47b17769754222a1e82e54d208dedb
work_keys_str_mv AT srivarshinicherukupallimohan currentstatusofbreastorganoidmodels
AT tianyulee currentstatusofbreastorganoidmodels
AT armandoegiuliano currentstatusofbreastorganoidmodels
AT xiaojiangcui currentstatusofbreastorganoidmodels
_version_ 1718444470694838272